April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Tom Powles shares final analysis results of BOND-003 trial for High-Risk NMIBC
Apr 28, 2025, 16:33

Tom Powles shares final analysis results of BOND-003 trial for High-Risk NMIBC

Tom Powles, Professor at the University of London, shared a post on X:

“BOND-003: The final analysis of Intravesical Cretostimogene Grenadenorepvec (n=112). for High-Risk BCG unresponsive NMIBC with CIS. CR=75% & 12 months DFS= 50% (of ITT population). This looks in line with other adenoviral gene therapies – INFa (adstiladein).”

Tom Powles shares final analysis results of BOND-003 trial for High-Risk NMIBC

More posts featuring Tom Powles.